US Broker Ratings

ICU Medical, Inc. (ICUI): Analyzing the 40% Potential Upside Amidst Market Challenges

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the medical instruments and supplies industry, is drawing considerable attention from investors due to its promising potential..

Crinetics Pharmaceuticals, Inc. (CRNX) Investor Outlook: Unpacking the 130% Potential Upside

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) has emerged as a notable player in the biotechnology sector with its focus on developing novel therapies for rare endocrine diseases..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Unpacking a 42% Potential Upside with Promising Biotech Innovations

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has positioned itself as an intriguing player in the biotechnology sector, particularly within the eye care segment. With its focus on..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring a 62.76% Potential Upside in Biotech

Investors seeking opportunities in the biotechnology sector might want to turn their attention to NewAmsterdam Pharma Company N.V. (NAMS). With its headquarters in Naarden, Netherlands, NewAmsterdam..

Organon & Co. (OGN) Stock Analysis: Unlocking a 45.33% Potential Upside Amidst Market Challenges

Organon & Co. (NYSE: OGN), a key player in the healthcare sector focusing on prescription therapies and medical devices, presents a compelling opportunity for investors despite..

Ardent Health, Inc. (ARDT) Stock Analysis: Healthcare Giant with a 51.87% Potential Upside

Ardent Health, Inc. (ARDT) is commanding attention in the healthcare sector with its extensive network of hospitals and clinics across the United States. Specializing in a..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Biotech Gem with 115% Upside Potential

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a key player in the biotechnology sector, presents a compelling opportunity for investors seeking exposure to the healthcare industry’s cutting-edge treatments..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential 44.03% Upside in the Healthcare Sector

Investors in the healthcare sector might want to keep a close eye on Perrigo Company plc (NYSE: PRGO), a renowned player in the drug manufacturing industry..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Promising 19.66% Upside in the Medical Devices Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC) is capturing investors’ attention with a compelling potential upside of 19.66%, as it continues to make significant strides in the medical..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A Look at Its 194% Potential Upside

Ultragenyx Pharmaceutical Inc. (RARE), a pioneering entity in the biotechnology sector, is capturing investor attention with its remarkable 194% potential upside, according to recent analyst ratings...

LifeStance Health Group, Inc. (LFST) Stock Analysis: Strong Buy Ratings Point to 56% Upside Potential

LifeStance Health Group, Inc. (NASDAQ: LFST) is making waves in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $2.1..

Arrowhead Pharmaceuticals (ARWR) Investor Outlook: Exploring a Biotech Pioneer with a 111% Potential Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) presents a compelling opportunity in the biotechnology sector, a field known for its potential to deliver groundbreaking treatments and substantial returns..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: A Biotech with 99% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is capturing attention in the biotechnology sector with its promising portfolio of treatments for rare diseases. The company’s market cap stands..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unpacking a Biotech Giant’s 353% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX), a prominent player in the biotechnology sector, has captured the attention of investors with its groundbreaking work in immunotherapy and a staggering..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A Biotech Bet with 102% Upside Potential

Denali Therapeutics Inc. (NASDAQ: DNLI), a prominent player in the biotechnology sector, is capturing the attention of investors with its ambitious pipeline and compelling upside potential...

PTC Therapeutics, Inc. (PTCT): Analyst Consensus Reveals 35.27% Potential Upside for Biotech Innovator

PTC Therapeutics, Inc. (NASDAQ: PTCT) is carving a niche in the biotechnology sector with its focus on rare disorders. Headquartered in Warren, New Jersey, PTC Therapeutics..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Exploring a 35% Upside Potential with Promising Clinical Developments

For investors with a keen interest in the biotechnology sector, Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) presents a compelling opportunity. This Pennsylvania-based company, with a market..

Arcellx, Inc. (ACLX) Stock Analysis: Exploring a 65% Potential Upside in Biotechnology

Arcellx, Inc. (NASDAQ: ACLX) is making waves in the biotechnology sector, drawing significant investor attention with its promising pipeline of immunotherapies and a notable potential upside...

Zai Lab Limited (ZLAB) Stock Analysis: A Biotech Gem with 65% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB) stands out in the biotechnology sector with its robust pipeline and strategic collaborations poised to address critical medical conditions. Headquartered in..

Vericel Corporation (VCEL) Investor Outlook: Exploring a 50.53% Potential Upside

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, is capturing investor attention with its remarkable potential upside of 50.53%, as indicated by recent..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds